Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124035152 | 12403515 | 2 | F | 20160901 | 20160525 | 20160909 | EXP | AU-009507513-1605AUS007481 | MERCK | 74.00 | YR | M | Y | 95.00000 | KG | 20160909 | CN | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124035152 | 12403515 | 1 | SS | PROPOFOL. | PROPOFOL | 1 | Intravenous (not otherwise specified) | 140 MG, UNK | U | 0 | 140 | MG | INFUSION | ||||||
| 124035152 | 12403515 | 2 | SS | PROPOFOL. | PROPOFOL | 1 | Intravenous (not otherwise specified) | 100 MG, UNK | U | 0 | 100 | MG | INFUSION | ||||||
| 124035152 | 12403515 | 3 | SS | PROPOFOL. | PROPOFOL | 1 | Intravenous (not otherwise specified) | 20 MG, UNK | U | 0 | 20 | MG | INFUSION | ||||||
| 124035152 | 12403515 | 4 | PS | ROCURONIUM BROMIDE. | ROCURONIUM BROMIDE | 1 | Intravenous (not otherwise specified) | 40 MG, UNK | U | 20214 | 40 | MG | SOLUTION FOR INJECTION | ||||||
| 124035152 | 12403515 | 5 | SS | FENTANYL. | FENTANYL | 1 | Intravenous (not otherwise specified) | 100 MICROGRAM, UNK | U | 0 | 100 | UG | |||||||
| 124035152 | 12403515 | 6 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 2 MG, UNK | U | 0 | 2 | MG | INJECTION | ||||||
| 124035152 | 12403515 | 7 | SS | bupivacaine hydrochloride (+) lidocaine | BUPIVACAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDE | 1 | 6 ML 2% LIGNOCAINE AND 0.5% BUPIVAKAINE 50:50 MIX | U | 0 | 6 | ML | ||||||||
| 124035152 | 12403515 | 8 | SS | SEVOFLURANE. | SEVOFLURANE | 1 | 3-4% IN AIR/02 MIX. | U | 0 | ||||||||||
| 124035152 | 12403515 | 9 | SS | glycopyrrolate (+) neostigmine methylsulfate | GLYCOPYRROLATENEOSTIGMINE | 1 | 2.5 MG/0.4 MG, UNK | U | 0 | ||||||||||
| 124035152 | 12403515 | 10 | SS | NALOXONE (naloxone hydrochloride) | NALOXONE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0.4 MG, UNK | U | 0 | .4 | MG | |||||||
| 124035152 | 12403515 | 11 | SS | SUCCINYLCHOLINE CHLORIDE. | SUCCINYLCHOLINE CHLORIDE | 1 | Intravenous (not otherwise specified) | 100 MG, UNK | U | 0 | 100 | MG | |||||||
| 124035152 | 12403515 | 12 | C | ASPIRIN. | ASPIRIN | 1 | UNK | U | 0 | TABLET | |||||||||
| 124035152 | 12403515 | 13 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | 0 | ||||||||||||
| 124035152 | 12403515 | 14 | C | METOPROLOL. | METOPROLOL | 1 | UNK | U | 0 | ||||||||||
| 124035152 | 12403515 | 15 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | U | 0 | ||||||||||
| 124035152 | 12403515 | 16 | C | PANADOL | ACETAMINOPHEN | 1 | UNK | U | 0 | ||||||||||
| 124035152 | 12403515 | 17 | C | GTN | NITROGLYCERIN | 1 | PRN, FORMULATION: SPRAY | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124035152 | 12403515 | 1 | Induction of anaesthesia |
| 124035152 | 12403515 | 4 | Induction of anaesthesia |
| 124035152 | 12403515 | 7 | Local anaesthesia |
| 124035152 | 12403515 | 9 | Anaesthesia reversal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124035152 | 12403515 | OT |
| 124035152 | 12403515 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124035152 | 12403515 | Acute myocardial infarction | |
| 124035152 | 12403515 | Anaesthetic complication pulmonary | |
| 124035152 | 12403515 | Cough | |
| 124035152 | 12403515 | Cyanosis | |
| 124035152 | 12403515 | Depressed level of consciousness | |
| 124035152 | 12403515 | Dyskinesia | |
| 124035152 | 12403515 | Electrocardiogram ST segment depression | |
| 124035152 | 12403515 | Emotional distress | |
| 124035152 | 12403515 | Endotracheal intubation complication | |
| 124035152 | 12403515 | Heart rate increased | |
| 124035152 | 12403515 | Hypertensive crisis | |
| 124035152 | 12403515 | Limb discomfort | |
| 124035152 | 12403515 | Oxygen saturation decreased | |
| 124035152 | 12403515 | Respiratory failure | |
| 124035152 | 12403515 | Troponin increased | |
| 124035152 | 12403515 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |